Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.04 USD | +0.10% | +3.63% | +20.10% |
Apr. 17 | IGM Biosciences, Sanofi Narrow Partnership to Focus on Potential Immunology and Inflamation Targets | MT |
Apr. 17 | IGM Biosciences, Inc. Announces Refocusing of Sanofi Collaboration | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.10% | 591M | |
+9.67% | 106B | |
+0.75% | 104B | |
+6.72% | 23.25B | |
-13.62% | 22.5B | |
-6.64% | 18.7B | |
-37.26% | 17.95B | |
-11.44% | 16.99B | |
+8.71% | 14.26B | |
+38.83% | 12.76B |
- Stock Market
- Equities
- IGMS Stock
- News IGM Biosciences, Inc.
- Morgan Stanley Adjusts IGM Biosciences Price Target to $8 From $15, Maintains Equal Weight Rating